Literature DB >> 1933376

Acute amphetamine-induced subsensitivity of A10 dopamine autoreceptors in vitro.

V Seutin1, P Verbanck, L Massotte, A Dresse.   

Abstract

Extracellular recordings were obtained from spontaneously active, presumed dopamine (DA) neurons of the ventral tegmental area (VTA) of the rat in a slice preparation. Bath-applied (+)-amphetamine (AMPH) (1-30 microM) induced a concentration-dependent decrease in the firing rate of these neurons, which tended to saturate with the highest concentrations used (n = 11). This inhibitory effect was dependent on the activation of D2 receptors since it was reversed by the D2 antagonist sulpiride (n = 8). However, the most striking effect of AMPH was the induction of a prominent subsensitivity of DA autoreceptors: whereas in 18 out of 20 control neurons, the D2 agonist BHT 920 (100 nM) produced a rapid and complete inhibition of the firing, this was observed in none out of 11 neurons 10 min after the end of the application of AMPH (1-30 microM) (P less than 0.001). In these cells, the mean percent inhibition produced by BHT 920 was only 47 +/- 8%. This subsensitivity remained unchanged after 20 min and declined after one hour. This effect was specific, since the sensitivity of GABAB receptors to baclofen (500 nM-1 microM) was not modified by the application of AMPH (n = 12). These results suggest that AMPH-induced DA autoreceptor subsensitivity can be produced acutely and may be the first step in a cascade of events leading to behavioral sensitization to this compound.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1933376     DOI: 10.1016/0006-8993(91)90731-a

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  13 in total

1.  Methamphetamine produces bidirectional, concentration-dependent effects on dopamine neuron excitability and dopamine-mediated synaptic currents.

Authors:  Sarah Y Branch; Michael J Beckstead
Journal:  J Neurophysiol       Date:  2012-05-16       Impact factor: 2.714

2.  Neonatal quinpirole treatment enhances locomotor activation and dopamine release in the nucleus accumbens core in response to amphetamine treatment in adulthood.

Authors:  Zackary A Cope; Kimberly N Huggins; A Brianna Sheppard; Daniel M Noel; David S Roane; Russell W Brown
Journal:  Synapse       Date:  2010-04       Impact factor: 2.562

3.  Amphetamine effects on dopamine release and synthesis rate studied in the Rhesus monkey brain by positron emission tomography.

Authors:  P Hartvig; R Torstenson; J Tedroff; Y Watanabe; K J Fasth; P Bjurling; B Långström
Journal:  J Neural Transm (Vienna)       Date:  1997       Impact factor: 3.575

4.  Amphetamine blocks long-term synaptic depression in the ventral tegmental area.

Authors:  S Jones; J L Kornblum; J A Kauer
Journal:  J Neurosci       Date:  2000-08-01       Impact factor: 6.167

Review 5.  Dopamine D2 Receptor Supersensitivity as a Spectrum of Neurotoxicity and Status in Psychiatric Disorders.

Authors:  Richard M Kostrzewa; Karolina Wydra; Malgorzata Filip; Cynthia A Crawford; Sanders A McDougall; Russell W Brown; Dasiel O Borroto-Escuela; Kjell Fuxe; Raul R Gainetdinov
Journal:  J Pharmacol Exp Ther       Date:  2018-06-19       Impact factor: 4.030

6.  Amphetamine depresses excitatory synaptic transmission via serotonin receptors in the ventral tegmental area.

Authors:  S Jones; J A Kauer
Journal:  J Neurosci       Date:  1999-11-15       Impact factor: 6.167

7.  Amphetamine self-administration attenuates dopamine D2 autoreceptor function.

Authors:  Erin S Calipari; Haiguo Sun; Khalil Eldeeb; Deborah J Luessen; Xin Feng; Allyn C Howlett; Sara R Jones; Rong Chen
Journal:  Neuropsychopharmacology       Date:  2014-02-11       Impact factor: 7.853

8.  Perinatal Treatments with the Dopamine D₂-Receptor Agonist Quinpirole Produces Permanent D₂-Receptor Supersensitization: a Model of Schizophrenia.

Authors:  Richard M Kostrzewa; Przemysław Nowak; Ryszard Brus; Russell W Brown
Journal:  Neurochem Res       Date:  2015-11-07       Impact factor: 3.996

9.  Ruboxistaurin Reduces Cocaine-Stimulated Increases in Extracellular Dopamine by Modifying Dopamine-Autoreceptor Activity.

Authors:  Alexander G Zestos; Colleen Carpenter; Youngsoo Kim; Malcolm J Low; Robert T Kennedy; Margaret E Gnegy
Journal:  ACS Chem Neurosci       Date:  2018-11-08       Impact factor: 4.418

10.  D2-Like dopamine autoreceptor activation reduces quantal size in PC12 cells.

Authors:  E N Pothos; S Przedborski; V Davila; Y Schmitz; D Sulzer
Journal:  J Neurosci       Date:  1998-08-01       Impact factor: 6.167

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.